Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Investing Intel. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at ...

Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last year. There are currently no approved vaccines to protect against ...

which could lead to an oral alternative to checkpoint inhibitors like Merck & Co’s Keytruda (pembrolizumab). “In combination with its novel technology and expertise in drug discovery ...

The Board of Directors of Rusagro will consider the issue of paying dividends in early 2025 after the completion of the redomicilation. This was stated by Alexander Tarasov, Deputy General Director of ...